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Dysfunction of T helper 17 (Th17) cells leads to chronic inflammatory disorders. Signal 
transducer and activator of transcription 3 (STAT3) orchestrates the expression of 
proinflammatory cytokines and pathogenic cell differentiation from interleukin (IL)-17-
producing Th17 cells. However, the pathways mediated by STAT3 signaling are not fully 
understood. Here, we observed that Fos-related antigen 1 (FRA1) and JUNB are directly 
involved in STAT3 binding to sites in the promoters of Fosl1 and Junb. Promoter binding 
increased expression of IL-17 and the development of Th17 cells. Overexpression of Fra1 
and Junb in mice resulted in susceptibility to collagen-induced arthritis and an increase 
in Th17 cell numbers and inflammatory cytokine production. In patients with rheumatoid 
arthritis, FRA1 and JUNB were colocalized with STAT3 in the inflamed synovium. These 
observations suggest that FRA1 and JUNB are associated closely with STAT3 activation, 
and that this activation leads to Th17 cell differentiation in autoimmune diseases and 
inflammation.
Keywords: Fos-related antigen 1-JUnB, signal transducer and activator of transcription 3, T helper 17, autoimmune 
arthritis, inflammation
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inTrODUcTiOn
T helper 17 (Th17) cells are a pathogenic subset of T helper 
lymphocytes that play a key role in inflammatory disorders 
leading to a severe chronic immune inflammatory response. 
Th17 cells release several proinflammatory cytokines including 
interleukin (IL)-17A, IL-21, and IL-22 (1). IL-17A is an inflam-
matory cytokine produced predominantly by Th17  cells with 
strong effects on stromal cells. IL-17A induces inflammatory 
cytokine production and leukocyte recruitment, which act to link 
the innate and adaptive branches of immunity (2). Both IL-17A 
and Th17 cells are highly involved in the pathogenesis of several 
autoimmune diseases, including rheumatoid arthritis (RA) (3, 4), 
while playing a significant role in autoimmune disorders medi-
ated by excessive inflammation.
Signal transducer and activator of transcription 3 (STAT3) is 
an important transcription factor with DNA-binding properties 
whose activity is paramount to the inflammatory response. It has 
been suggested that STAT3 activation upregulates IL-17 produc-
tion via Th17 cell proliferation (5, 6). Several transcription factors 
including STAT3 regulate Th17 cell differentiation (7–12); how-
ever, STAT3 also plays a key role in the immune inflammatory 
response. There is a general consensus that STAT3 is essential for 
Th17  cell differentiation (13). Moreover, STAT3 modulates the 
production of several cytokines including IL-17A and activates 
downstream transcription factors, such as RAR-related orphan 
receptor gamma isoform 2 (RORγt), which is responsible for the 
Th17 phenotype (14, 15).
The activator protein 1 (AP-1) family is a group of structurally 
and functionally related JUN (c-JUN, JUNB, and JUND) and 
FOS [c-FOS, FOSB, Fos-related antigen 1 (FRA1), and FRA2] 
transcription factors. AP-1 heterodimers are involved in a variety 
of biological processes including cell proliferation, differentia-
tion, apoptosis, and inflammation (16, 17). It has been suggested 
that AP-1 proteins are involved in several pathological conditions 
(18–21), while JUN and FOS proteins are also associated with 
the immune inflammatory response. Modulation of c-FOS and 
c-JUN expression is critical for inhibition of IL-17 production 
(22) and the maintenance of suppressive regulatory T-cell 
function (23). Additionally, production of FRA1, a member of 
the FOS protein family, is increased by B cell stimulation (24). 
Furthermore, JUNB modulates the proliferation of B cells (25). 
This evidence suggests that FRA1 and JUNB may be involved in 
regulating the inflammatory immune response.
We hypothesized that FRA1 and JUNB modulate the 
Th17 cell-mediated inflammatory response. The aim of this study 
was to elucidate whether FRA1 and JUNB regulate autoimmune 
arthritis via Th17 cell differentiation and factors downstream of 
STAT3. We used in vitro models, in vivo animal models, and clini-
cal specimens from patients with RA to investigate the biological 
importance of this pathway.
MaTerials anD MeThODs
Mice
Collagen-induced arthritis (CIA) was induced in 6–8-week-old 
male DBA/1J, BALB/c, and C57BL/6 mice (Orient, Korea). 
To generate Fra1/Junb Tg mice, a pcDNA3.1+HA (Invitrogen, 
CA, USA) vector containing the FRA1 and JUNB proteins 
coupled to a linker peptide (3 × GGGGS) was constructed. The 
Fra1/Junb fragment was synthesized by GenScript Corporation 
(NJ, USA), with codon optimization for expression in mamma-
lian cells. Fra1/Junb Tg mice were bred from the C57BL/6 line 
and maintained in facilities at Macrogen Laboratories (Seoul, 
Korea). All mice were maintained under specific-pathogen-free 
conditions at the Institute of Medical Science, The Catholic 
University of Korea. The presence of the transgene in the found-
ers was confirmed by PCR of genomic DNA extracted from 
the tail samples. Genotyping was performed by PCR analysis 
of genomic DNA obtained from mice at 3  weeks of age. All 
experimental procedures were examined and approved by the 
Animal Research Ethics Committee at the Catholic University 
of Korea.
accession codes
Raw RNA-seq data have been deposited in the NCBI Sequence 
Read Archive (SRR6320798 and SRR6320799).
A detailed description of all other experimental procedures and 
the statistical analysis is provided in the Section “Supplementary 
Materials and Methods” in Data Sheet S1 in Supplementary Material.
resUlTs
sTaT3 Target genes are Differentially 
expressed in Mouse Th17 cells
Potential STAT3-binding sites were identified using publicly avail-
able chromatin immunoprecipitation sequencing (ChIP-Seq) data 
cross-referenced with differentially expressed genes in Th17 cells 
(14). We sequenced mRNA obtained from Th17 cells and naïve 
T cells and compared the results with potential STAT3-binding 
targets identified by ChIP-Seq to identify STAT3-regulated genes 
involved in Th17 cell differentiation. The literature was system-
atically reviewed for downstream STAT3 targets in humans and 
mice in multiple biological contexts. By combining these three 
datasets, we searched for genes with STAT3-binding sites that 
are upregulated during Th17  cell differentiation (Figure  1A; 
Table S1 in Supplementary Material). RNA-Seq was performed 
to identify genes differentially expressed between Th17 cells and 
naïve T cells. This integrated approach suggested that Fosl1 (the 
gene locus of Fra1) and Junb are Th17 cell differentiation factors 
downstream of STAT3. As shown in Figures 1B–F and Table S2 in 
Supplementary Material, Fos and Jun were the predominant AP-1 
subtypes expressed in naïve (CD4+CD62L+) T cells, whereas Fosl1 
and Junb were the predominant subtypes in Th17 cells. Other AP-1 
subtypes were downregulated, suggesting that Fosl1 and Junb 
AP-1 subtypes play an important role in Th17 cell differentiation.
Fra1 and Junb are highly expressed in 
Th17 cells, and Their expression is 
regulated Directly by sTaT3 in Mice
Quantitative real-time reverse transcription PCR (qRT-PCR) 
and immunoblot analyzes were used to confirm Fra1 and Junb 
FigUre 1 | Signal transducer and activator of transcription 3 (STAT3) target genes are differentially expressed in naïve and T helper 17 (Th17) cells. Naïve 
T cells (CD4+CD62L+) were isolated from 6-week-old mice (n = 3), stimulated under Th17-polarizing conditions for 3 days, and then sorted for CD4+CD62L− 
expression. RNA was sequenced using the Illumina GA IIx. STAT3 chromatin immunoprecipitation sequencing (ChIP-Seq) data for CD4+ T cells were 
downloaded from the NCBI Sequence Read Archive (SRP002451). (a) A comparison of differentially expressed genes identified by RNA-Seq, STAT3-binding 
target genes identified by ChIP-Seq, and the downstream targets of STAT3. The expression of (B) IL17a and (c–F) activator protein 1 transcription factor target 
genes [(c) Fos, (D) Jun, (e) Fosl1, and (F) Junb] was compared between naïve T cells and Th17 cells, with reference to STAT3-binding target genes (obtained 
from STAT3 ChIP-Seq data in Th17 cells). The peak profiles are color-coded as follows: naïve T cells (RNA-Seq: blue), Th17 cells (RNA-Seq: red), and 
STAT3-binding genes (ChIP-Seq: green).
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expression. Among the various AP-1 subtypes, only Fra1 and Junb 
mRNA levels were significantly increased in Th17 cells compared 
with naive T  cells (Figures  2A,B). These findings supported 
the RNA-Seq results. Immunoblot analysis also showed high 
levels of FRA1 and JUNB expression in Th17 cells (Figure 2C). 
Co-immunoprecipitation studies were performed using antibod-
ies against Jun family proteins (i.e., JUNB and c-JUN), followed 
by immunoblotting using antibodies against FOS family proteins 
(i.e., FRA1, c-FOS, and FOSB) to determine whether FRA1 and 
JUNB form a heterodimeric AP-1 complex. It was found that FRA1 
forms a complex with JUNB, but not with c-JUN (Figure 2D).
Next, we investigated the functional association between the 
FRA1–JUNB complex and STAT3. The STAT3 signaling pathway 
was inhibited using genetically engineered STAT3-deficient 
CD4+ T  cells and STA-21, which blocks the DNA-binding 
activity of STAT3 (26). As shown in Figure  3A, CD4+ T  cells 
harboring Stat3fl/flCd4-Cre had markedly decreased levels of 
Fra1 and Junb mRNA under both neutral and Th17-polarizing 
conditions. Treatment with STA-21 profoundly decreased the 
expression of FRA1, JUNB, and STAT3 (Figure 3B). Moreover, 
STA-21 decreased the levels of STAT3 phosphorylation under 
Th17-polarizing conditions (Figure 3C). STAT3 overexpression 
increased the relative levels of Fra1 and Junb mRNA (Figure 3D), 
while in  vitro treatment with IL-6 upregulated Fra1 and Junb 
mRNA (Figure 3E).
Co-immunoprecipitation studies were performed using anti-
FRA1 and anti-JUNB antibodies followed by immunoblotting 
with antibodies against STAT3 to determine whether FRA1 and 
JUNB physically interact with STAT3. Both FRA1 and JUNB 
were found to form a complex with STAT3 (Figure  3F). We 
performed ChIP and qPCR to examine whether STAT3 binds 
directly to the promoter regions of Fosl1 and Junb. The ChIP-
qPCR results were compared with publicly available ChIP-Seq 
data from Th17  cells. We found that STAT3 binds to the pre-
dicted recognition sites upstream of Fosl1 and Junb, suggesting 
that it regulates their expression by binding directly to their 
promoters (Figure 3G). Using confocal microscopy, we found 
that FRA1 and JUNB were colocalized with phosphorylated 
STAT3 in CD4+ splenic T cells and Th17 cells from arthritic mice 
(Figures 3H,I). These findings suggest that STAT3 signaling is 
critical for the expression and activation of FRA1 and JUNB 
during Th17 cell differentiation.
FigUre 2 | Both Fos-related antigen 1 (FRA1) and JUNB are highly expressed in T helper 17 (Th17) cells. (a,B) Naïve T cells (CD4+CD62L+) were isolated from 
6-week-old C57BL/6 mice (n = 3) and cultured for 3 days under the indicated promoters. Relative mRNA levels were measured by qRT-PCR. (c) Protein extracts 
were prepared from CD4+ T cells (Tconv) and CD4+ T cells cultured for 3 days under Th17-polarizing conditions (Th17). FRA1 and JUNB protein levels were 
evaluated by immunoblotting. (D) CD4+ T cells cultured under Th17-polarizing conditions were lysed, and the cell lysates were subjected to co-immunoprecipitation 
with anti-JUNB and anti-c-JUN antibodies and immunoblotting with anti-FRA1, anti-c-FOS, and anti-FOSB antibodies. Data are representative of three (a–c) or two 
(D) independent experiments, each performed in triplicate (a,B). The data were analyzed using an unpaired t-test or one-way ANOVA with Bonferroni’s post hoc 
test. Error bars show the SEM. *p < 0.05, **p < 0.005, and ***p < 0.0005.
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expression of il-17 is Directly regulated 
by the Fra1–JUnB complex
The AP-1 family plays a versatile role in T-cell development (27). 
Levels of IL-17 were measured in Fra1- and Junb-overexpressing 
and silenced cells. The relative levels of IL17 mRNA were sig-
nificantly increased in cells overexpressing Fra1 and Junb. The 
relative mRNA levels of other genes associated with Th17 cells, 
such as IL21, IL22, and Rorc (the RORγt gene locus), were also 
increased (Figures  4A,B). CD4+IL-17+ cells and IL17 mRNA 
levels were significantly decreased when Fra1 and Junb were 
silenced under Th17-polarizing conditions (Figures  4C,D). By 
contrast, when c-Fos and c-Jun, the dominant AP-1 subtypes 
in naïve T  cells, were overexpressed, IL17 mRNA levels were 
decreased significantly (Figures  4E,F). These findings support 
the specificity of the role of the FRA1–JUNB complex in Th17 cell 
differentiation.
We next investigated whether the FRA1–JUNB complex 
directly regulates IL-17 expression by binding to the IL17a 
promoter. The interaction between the FRA1–JUNB complex and 
the AP-1-binding motif within the IL17a promoter region was 
examined by electrophoretic mobility shift assay. The anti-FRA1 
and anti-JUNB antibodies caused a super shift of the labeled 
DNA probe, indicating that the AP-1-binding motif interacts 
specifically with FRA1 and JUNB (Figure 4G). This finding was 
confirmed by an analysis of the IL17a promoter using a lucif-
erase reporter system. Overexpression of both FRA1 and JUNB 
increased luciferase activity in EL4 cells. Simultaneous overex-
pression of FRA1 and JUNB caused luciferase activity to increase 
twofold (Figure 4H). Silencing of Fra1 and Junb caused a greater 
than twofold reduction in luciferase activity. Simultaneous over-
expression of c-FOS and c-JUN caused a significant decrease in 
the luciferase activity induced by the IL17a promoter (Figure 4I). 
ChIP-qPCR analyses showed that FRA1 and JUNB bind directly 
to the IL17a gene loci and to gene loci encoding other Th17 cell 
differentiation activators, such as IL21, IL22, and Rorc (Figure 4J). 
These findings indicate that the FRA1–JUNB complex binds to 
FigUre 3 | Signal transducer and activator of transcription 3 (STAT3)-mediated activation of Fos-related antigen 1 (FRA1) and JUNB in T helper 17 (Th17) cells.  
(a) CD4+ T cells from Stat3fl/fl and Stat3fl/flCd4-Cre were isolated (left panel) or cultured under Th17-polarizing conditions for 3 days (right panel). (B,c) CD4+ T cells 
were pretreated with STA-21 for 1 day, cultured under Th17-polarizing conditions for a further 3 days, and then treated with interleukin (IL)-6 for 2 h (c) before 
harvesting and lysing. (D) LBRM cells were transfected with a STAT3 expression vector, and the cells were cultured for 3 weeks in the presence of neomycin  
(10 µg/ml). (e) CD4+ T cells were cultured in the presence of IL-6 for 16 h. (F) CD4+ T cells were cultured under Th0- or Th17-polarizing conditions for 3 days and the 
lysed. The cell lysates were subjected to immunoprecipitation with an anti-phospho-STAT3Y705 antibody and immunoblotting with anti-phospho-FRA1 or anti-
phospho-JUNB antibodies. (g) The STAT3-binding region (green) detected by STAT3 chromatin immunoprecipitation (ChIP) sequencing in Th17 cells is shown along 
with the Fosl1 and Junb loci, including the primer sites (yellow boxes) (left panel). The negative control cyclophilin showed no enrichment (data not shown). CD4+ 
T cells were cultured under Th17-polarizing conditions for 3 days. ChIP-qPCR analysis was performed using an anti-STAT3 antibody and primers specific for Fosl1 
and Junb (right panel). (h,i) Splenic tissue was collected from collagen-induced arthritis mice. CD4+ splenic T cells and Th17 cells from arthritic mice were stained 
for CD4 (white), FRA1, JUNB (green), and phospho-STAT3Y705 (h) or DAPI (i) (blue). Data are representative of three (B–i) and two (a) independent experiments, 
each performed in triplicate (a,D,e,g). The data were analyzed using an unpaired t-test; error bars show the SEM. *p < 0.05, **p < 0.005, and ***p < 0.0005.
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the IL17a promoter region, and that this binding activates IL17 
gene transcription.
Fra1 and JUnB are critical for the 
Pathogenesis of cia
T helper 17 cells and IL-17 contribute significantly to the develop-
ment of RA (28, 29). To examine the in vivo role of the FRA1–
JUNB complex in rheumatoid inflammation, Fra1 and Junb were 
silenced in CIA mice by injecting Fra1 and Junb short hairpin 
RNA vectors. This markedly reduced the incidence of arthritis 
and decreased the arthritis score (Figure 5A). The numbers of 
FRA1+, JUNB+, and IL-17+ cells were significantly lower within 
the joint tissues (Figure 5B). Histological examination showed 
that the ankle joints of Fra1/Junb-silenced mice had less inflam-
mation and cartilage damage (Figure 5C). Inhibition of Fra1/Junb 
also reduced the expression of Th17 cytokines such as IL-6, IL-17, 
IL-1β, and tumor necrosis factor-α in joint tissue. Other mediators 
of joint destruction such as vascular endothelial growth factor 
and receptor activator of nuclear factor κB ligand (RANKL) were 
also downregulated (Figure S1A in Supplementary Material). In 
CIA mice, disease severity was correlated with the level of type 
II collagen (CII)-specific IgG antibodies (30). Silencing of Fra1 
and Junb reduced T-cell proliferation and CII-specific antibody 
production (Figures S1B,C in Supplementary Material). It also 
FigUre 4 | Expression of interleukin (IL)-17 is directly mediated by the Fos-related antigen 1 (FRA1)–JUNB complex in T helper 17 (Th17) cells. LBRM cells were 
transfected with vectors and cultured for 3 weeks with neomycin (10 µg/ml) (a,B,e,F). (a,B) The relative mRNA levels of each gene were measured by qRT-PCR. 
(c,D) CD4+ T cells were infected with lentiviruses harboring constructs designed to knockdown Fra1 and Junb. Cells were then cultured under Th17-polarizing 
conditions for 3 days. CD4+IL-17+ T cells were identified by flow cytometry, and relative mRNA levels were measured by qRT-PCR. (e,F) The relative mRNA level of 
each gene was measured by qRT-PCR. (g) Nuclear extracts from Th17 cells were analyzed by electrophoretic mobility shift assay incorporating a radiolabeled 
probe derived from the activator protein 1-binding site of the IL17a locus and antibodies specific for FRA1 or JUNB. (h,i) EL4 cells were transiently transfected with 
expression vectors and IL17a promoter constructs with a CNS2 enhancer region. Luciferase activity was measured using a dual-luciferase reporter assay system. 
(J) CD4+ T cells were cultured under Th17-polarizing conditions. Chromatin immunoprecipitation-qPCR was performed using anti-FRA1 or anti-JUNB antibodies 
with primers specific for each gene locus. Data are representative of at least three independent experiments, performed in triplicate. Data were analyzed using an 
unpaired t-test; error bars show the SEM. *p < 0.05, **p < 0.005, and ***p < 0.0005.
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substantially reduced the population of IL-17-producing CD4+ 
T cells, considered to be Th17 cells, in the spleen and draining 
lymph nodes (Figure S1D in Supplementary Material).
CD4+ T cells in Fra1/Junb Tg mice had different proportions 
of Th1 and Th17  cells (Figure S2 in Supplementary Material). 
CIA was induced in Fra1/Junb transgenic mice to investigate 
the in vivo effects of Fra1 and Junb overexpression. Splenocytes 
were examined for HA-tagged FRA1/JUNB transgene by 
immunoblotting (Figure  5D). The incidence of arthritis and 
the arthritis score were significantly increased (Figures  5E,F). 
There was a marked increase in the levels of IL-17, FRA1, and 
JUNB in the spleen (Figure 5G). The relative mRNA level of the 
osteoclastogenic marker tartrate-resistant acid phosphatase was 
significantly higher (Figure 5H), while CII-specific T-cell prolif-
eration and IgG production were also increased (Figures 5I–K). 
Overexpression of FRA1/JUNB profoundly increased CIA 
FigUre 5 | Fos-related antigen 1 (FRA1) and JUNB are involved in the pathogenesis of collagen-induced arthritis, T helper 17 cell differentiation, and rheumatoid 
inflammation in mice. Arthritis was induced in mice, and shRNA control or shRNAFra1/shRNAJunb vectors were injected on days 7 and 14 (n = 5–7). (a) Arthritis 
severity was measured using the incidence and mean arthritis score. (B) Splenic tissue from each mouse was stained. Positively stained cells were counted visually 
by four individuals from high-magnification images projected onto a screen, and the mean values are presented as a histogram. (c) On day 30 after immunization, 
tissues were sampled from the ankle joints and stained with toluidine blue, Safranin O (scale bar = 100 µm), H&E [scale bar = 500 µm (left); 100 µm (right)], or 
tartrate-resistant acid phosphatase (TRAP) (scale bar = 200 µm). The inflammation and cartilage scores are shown in bar graphs (right panel). (D) Splenocytes were 
examined for the HA-tagged FRA1/JUNB transgene by immunoblotting. (e,F) Disease severity was recorded using the incidence and mean arthritis score.  
(g) Splenic tissue from each mouse was stained for FRA1, JUNB, and interleukin-17 in CD4+ T cells and examined by laser confocal microscopy. (h) The relative 
levels of TRAP mRNA in cells from the ankle joints were measured by qRT-PCR. (i) T-cell proliferation was analyzed using a mixed-lymphocyte reaction. (J,K) The 
levels of IgG1 and IgG2a antibodies specific to type II collagen were measured in serum. Data are representative of more than two independent experiments. Data 
were analyzed using an unpaired t-test or two-way ANOVA with Bonferroni’s post hoc test; error bars show the SEM. *p < 0.05, **p < 0.005, and ***p < 0.0005.
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joint pathology (Figure S3A in Supplementary Material). 
Immunostaining showed that the expression of various proinflam-
matory cytokines and RANKL, a mediator of osteoclastogenesis, 
was significantly greater in the joint tissues of transgenic mice 
with CIA (Figure S3B in Supplementary Material). IL-17 mRNA 
levels and Th17 cell numbers were increased markedly (Figures 
FigUre 6 | Expression and potential function of Fos-related antigen 1 (FRA1) and JUNB in rheumatoid arthritis (RA) patients. (a,B) Flow cytometry, qRT-PCR, and 
ELISA. CD4+ T cells were isolated from healthy peripheral blood mononuclear cells (PBMCs) and infected with retroviruses containing FRA1 on day 1. The infected 
cells were then cultured under T helper 17 (Th17)-polarizing conditions for 3 days and analyzed. (c) qRT-PCR and ELISA. CD4+ T cells from healthy controls were 
infected with lentiviruses harboring constructs designed to knockdown Fra1. Cells were then cultured under Th17-polarizing conditions for 3 days. (D) qRT-PCR 
analysis. Total RNA was extracted from PBMCs isolated from healthy controls and from PBMCs and synovial fluid mononuclear cells (SFMCs) from RA patients.  
(e) ELISA. CD4+ T cells in SFMCs from RA patients were infected with lentiviruses harboring constructs designed to knockdown Fra1. Cells were then cultured 
under Th17-polarizing conditions for 3 days. (F) Synovial tissue obtained from RA patients. Sections were immunostained. Data are representative of three  
(a–c,F) and two (D,e) independent experiments, each performed in triplicate. (g) A schematic illustration of the inflammatory signaling pathway mediated by FRA1/
JUNB. (B–e) Data are representative of more than three independent experiments. Data were analyzed using an unpaired t-test; error bars show the SEM. 
*p < 0.05, **p < 0.005, and ***p < 0.0005.
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S3C,D in Supplementary Material). These findings suggest that 
the FRA1–JUNB complex plays a major role in the development 
of CIA, likely through the induction of Th17 cell differentiation.
expression and Potential Functions of 
Fra1 and JUnB in ra Patients
We demonstrated in vivo roles of FRA1 and JUNB in mice with 
CIA, an animal disease model for RA. To confirm the roles of 
FRA1 and JUNB in patients with RA, FRA1 was overexpressed in 
CD4+ T cells isolated from healthy controls. FRA1 overexpression 
increased the proportion of IL-17-producing CD4+ T cells during 
Th17 polarization (Figure 6A). These cells produced significantly 
higher levels of IL17a mRNA and cytokines (Figure 6B). Fra1 
silencing decreased IL17a mRNA levels and IL-17 secretion 
(Figure 6C). There were significantly increased the transcription 
levels of Fra1 and Junb among peripheral blood mononuclear 
cells (PBMCs) and synovial fluid mononuclear cells (SFMCs) 
from RA patients compared with PBMCs from healthy controls 
(Figure  6D). Junb was also upregulated in RA patients. When 
Fra1 was silenced in CD4+ T cells isolated from SFMCs of RA 
patients, IL-17 secretion was decreased during Th17 polariza-
tion (Figure 6E). The expression of both FRA1 and JUNB was 
particularly high in the inflamed synovium of RA patients, a 
region enriched with inflammatory immune cells (Figure 6F). Of 
note, FRA1, JUNB, and phosphorylated STAT3 were colocalized 
in the inflamed synovium, which further supported our in vitro 
experimental results. A schematic illustration of the inflamma-
tory signaling pathway induced by FRA1/JUNB is shown in 
Figure  6G. Th17 conditioning induces an inflammatory signal 
by promoting FRA1/JUNB. The inflammatory response is medi-
ated by activation of STAT3, which regulates genes involved in 
Th17 cell differentiation. This cascade induces excessive inflam-
mation and autoimmunity resulting in RA.
DiscUssiOn
Although FRA1 and JUNB may have modulatory activity in the 
immune inflammatory response (18, 19), there is currently no 
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evidence in the literature to support this notion in autoimmune 
disorders mediated by STAT3 and Th17 cells. In this study, we 
found evidence of previously unidentified functions of FRA1 and 
JUNB in Th17 cell differentiation and autoimmune disease. We 
investigated the modulatory function and underlying mecha-
nisms of FRA1 and JUNB in a murine model of inflammatory 
arthritis. The predominant conclusion from this study was that 
FRA1 and JUNB exacerbate inflammation via the induction of 
Th17 cells. To our knowledge, this is the first study to implicate 
FRA1 and JUNB directly in STAT3 activation and regulation of 
Th17 cell proliferation. These observations suggest a previously 
unidentified function of these factors in autoimmune disease.
Activator protein 1 is comprised of dimers of FOS and JUN 
protein family members (31, 32). The diverse functions of AP-1 
family members result from heterodimer formation between the 
FOS and JUN proteins (33). AP-1 is also involved in cell func-
tions including proliferation, differentiation, and apoptosis. For 
example, the FRA2–JUND complex is involved in the terminal 
differentiation of granulosa cells into luteal cells (34) and T-cell 
activation (35). Additionally, AP-1 factors may play important 
roles in autoimmune disease and Th17 cell differentiation. It was 
suggested that basic leucine zipper transcription factor, ATF-like 
(BATF), an AP-1 protein, leads to increased Th17 cell differentia-
tion, whereas BATF deficiency results in IL-17 downregulation 
(12). Loss of the AP-1 family member Fosl2 in T cells improved 
EAE severity via suppression of Th17  cell plasticity (36). We 
performed an integrative analysis using RNA-Seq and ChIP-Seq 
data to identify key factors downstream of STAT3 involved in 
Th17 cell differentiation. This integrative analysis suggested that 
upregulation of Fra1 and Junb drives and promotes Th17  cell 
differentiation.
Signal transducer and activator of transcription 3-mediated 
IL-17 expression and Th17  cell differentiation involve AP-1 
family proteins. Previous studies have shown a biological link 
between the STAT3 signaling pathway and the AP-1 family of 
transcription factors (12, 37, 38). In particular, STAT3-mediated 
expression of BATF, an AP-1 subfamily member, is associated 
with Th17 cell differentiation (12). In this study, RNA-Seq analysis 
showed that the expression of cFos and cJun was higher in naïve 
T cells. This suggests that AP-1 subtype switching from c-FOS–
c-JUN to FRA1/JUNB is essential for Th17 cell differentiation. It 
can also be postulated that activation of c-FOS–c-JUN must be 
suppressed in parallel with activation of FRA1/JUNB by STAT3 
during polarization toward the Th17 subtype. The present study 
identified an AP-1 complex comprising FRA1 and JUNB, which 
appears to function as a key factor downstream of STAT3 in 
Th17 cell differentiation. It appears that AP-1 subtype switching, 
particularly from c-FOS, FOSB, and c-JUN to FRA1 and JUNB, is 
required for STAT3-mediated Th17 cell differentiation.
The AP-1 family includes the c-JUN and c-FOS proteins, which 
play important roles in IL-17 expression and Th17 cell functions. 
It has been demonstrated that BATF binds to intergenic compo-
nents in the IL17a locus and to IL17 promoters, both of which are 
essential for Th17 differentiation (12). Additionally, the BATF–
JUNB and BATF–JUND complexes have been shown to cooper-
ate with IRF4 in Th17 cells to promote transcription of IL17 (39). 
The c-JUN transcription factor that heterodimerizes with c-FOS 
to generate the AP-1 transcription factor complex is involved 
in suppression of IL-17 production in developing Th17  cells 
(16, 22). FRA2 is also a negative regulator of IL-17 (36). We 
observed that overexpression of FRA2 decreased the expression 
of IL17a in a promoter-fused luciferase reporter assay (data not 
shown). We also found that expression levels of c-Fos and c-Jun 
were significantly reduced, whereas Batf expression was increased 
in Th17 cells compared with naïve T cells. Overexpression of c-Fos 
and c-Jun significantly decreased IL17 mRNA levels. The FRA1–
JUNB complex directly activates expression of IL-17, a cytokine 
produced by Th17 cells. This complex plays a role in promoting 
the expression of other cytokines associated with Th17 cells, such 
as IL-21 and IL-22, by directly binding to their promoter regions. 
These results suggest that FRA1 and JUNB are involved in IL-17 
production and Th17 cell differentiation.
Although FRA1/JUNB and c-FOS/c-JUN compete for the 
same AP-1-binding sites within the IL17a promoter, we found 
in this study that IL17a promoter activity was increased by FRA1 
and JUNB overexpression but decreased by c-FOS and c-JUN 
overexpression. We observed an interaction between p-STAT3 
and p-FRA1 or p-JUNB in Th17  cells; therefore, FRA1/JUNB 
and c-FOS/c-JUN may be involved in AP-1 subtype switching. 
Additionally, p-FRA1 binds to p-JUNB in Th17  cells. Further 
study is needed to confirm the AP-1 subtype switching factors 
involved and the mechanism of interaction between p-FRA1 and 
p-JUNB in Th17 cells.
This study has certain limitations. One is that the animal 
studies were conducted using FRA1/JUNB-1 overexpression 
and knockdown vectors. Adoptive transfer studies in conditional 
overexpression and knockout mice are required to confirm that 
FRA1/JUNB-1 regulates CD4+ T  cells, leading to autoimmune 
arthritis. Nonetheless, this study is the first to demonstrate func-
tions of FRA1/JUNB-1 in Th17 cell differentiation and autoim-
mune arthritis. Future studies using adoptive transfer models 
with CD4+ T  cells differentially expressing FRA1/JUNB-1 are 
required to validate our data more precisely.
Uncontrolled Th17 cell activation is responsible for the onset 
of several autoimmune diseases. Th17 cells cause tissue injury via 
production of IL-17, as observed in CIA mouse models of disease. 
The present study showed that the FRA1–JUNB complex plays a 
central role in the development of RA, which is a Th17-mediated 
autoimmune disease. The FRA1–JUNB complex may be clini-
cally relevant as it functions as a Th17 cell-specific regulator of 
proinflammatory cytokine production in CIA mouse models 
and hence RA. In the RA mouse model used in this study, FRA1/
JUNB overexpression resulted in the development of severe 
inflammatory symptoms and augmented expression of IL-17 in 
mice. Notably, this has fueled interest in the genetic importance 
of FRA1/JUNB in human RA in the context of promoted STAT3 
activity. FRA1 overexpression activated Th17 cell differentiation 
in PBMCs from healthy controls; however, FRA1 silencing down-
regulated IL-17 production in SFMCs from RA patients. This may 
indicate the potential of the FRA1–JUNB complex as a thera-
peutic target in human autoimmune disease. In conclusion, our 
results suggest a previously unidentified function of FRA1/JUNB 
in T-cell-mediated autoimmune diseases. FRA1/JUNB directly 
modulates STAT3 activation and Th17 cell differentiation. Our 
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identification of the involvement of FRA1/JUNB in T-cell deve-
lopment provides a potential therapeutic target for the treatment 
of autoimmune diseases.
eThics sTaTeMenT
The Animal Care Committee of The Catholic University of 
Korea approved the experimental protocol. All experimental 
procedures were evaluated and carried out in accordance with the 
protocols approved by the Animal Research Ethics Committee 
at the Catholic University of Korea (CMCU-2012-0156-01). 
All procedures performed followed the ethical guidelines on 
animal use. Approval by the ethics committee of Seoul St. Mary’s 
Hospital (Seoul, Republic of Korea) was obtained for all proce-
dures. All human experimental procedures were approved by the 
Ethics Committee of Seoul St. Mary’s Hospital (Seoul, Republic 
of Korea, KC13TISE0032).
aUThOr cOnTriBUTiOns
Y-MM, S-YL, S-KK, SL, S-MA, and M-LC designed the experi-
ments and analyzed the data. Y-MM, S-YL, S-KK, and SL wrote the 
manuscript along with input from DK, WK, Y-MH, H-JS, E-KK, 
J-GR, H-BS, J-EK, S-YH, and JY. Y-MM and S-YL performed 
all in vitro assays with help from S-KK, SL, DK, WK, and H-BS. 
S-YL, H-JS, and J-GR performed the animal experiments. E-KK 
conducted all immunohistochemistry experiments. Y-MM, S-YL, 
S-KK, SL, RS, D-MJ, H-YK, S-HP, S-MA, and M-LC discussed 
and developed the study concept. All authors critically reviewed 
and approved the final form of the manuscript.
FUnDing
This study was supported by a grant of the Korean Health 
Technology R&D Project, Ministry for Health & Welfare, Republic 
of Korea (grant no. HI14C3417), by the Basic Science Research 
Program from the National Research Foundation of Korea funded 
by the Ministry of Education, Science and Technology (grant no. 
2012-0006135), and by a grant of the Korea Health Technology 
R&D Project through the Korea Health Industry Development 
Institute, funded by the Ministry of Health & Welfare, Republic 
of Korea (grant no. HI15C3062).
sUPPleMenTarY MaTerial
The Supplementary Material for this article can be found online at 
http://www.frontiersin.org/articles/10.3389/fimmu.2017.01793/
full#supplementary-material.
FigUre s1 | Knockdown of FRA1/JUNB Decreases Th17 Cell Differentiation 
and Attenuates Rheumatoid Inflammation in Mice.
FigUre s2 | T cell proportion of CD4+Tcells in Fra1/Junb Tg mice.
FigUre s3 | Overexpression of FRA1/JUNB Causes Th17 Cell Differentiation 
and Increases CIA Disease Severity.
reFerences
1. Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM, 
et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage dis-
tinct from the T helper type 1 and 2 lineages. Nat Immunol (2005) 6:1123–32. 
doi:10.1038/ni1254 
2. Iwakura Y, Nakae S, Saijo S, Ishigame H. The roles of IL-17A in inflammatory 
immune responses and host defense against pathogens. Immunol Rev (2008) 
226:57–79. doi:10.1111/j.1600-065X.2008.00699.x 
3. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, et  al. 
IL-17 plays an important role in the development of experimental auto-
immune encephalomyelitis. J Immunol (2006) 177:566–73. doi:10.4049/
jimmunol.177.1.566 
4. Kotake S, Udagawa N, Takahashi N, Matsuzaki K, Itoh K, Ishiyama S, 
et  al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a 
potent stimulator of osteoclastogenesis. J Clin Invest (1999) 103:1345–52. 
doi:10.1172/JCI5703 
5. Mathur AN, Chang HC, Zisoulis DG, Stritesky GL, Yu Q, O’Malley JT, et al. 
STAT3 and STAT4 direct development of IL-17-secreting Th cells. J Immunol 
(2007) 178:4901–7. doi:10.4049/jimmunol.178.8.4901 
6. O’Shea JJ, Paul WE. Mechanisms underlying lineage commitment and 
plasticity of helper CD4+ T cells. Science (2010) 327:1098–102. doi:10.1126/
science.1178334 
7. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, 
et  al. The orphan nuclear receptor RORgammat directs the differentiation 
program of proinflammatory IL-17+ T helper cells. Cell (2006) 126:1121–33. 
doi:10.1016/j.cell.2006.07.035 
8. Chaudhry A, Rudra D, Treuting P, Samstein RM, Liang Y, Kas A, et al. CD4+ 
regulatory T  cells control Th17 responses in a STAT3-dependent manner. 
Science (2009) 326:986–91. doi:10.1126/science.1172702 
9. Yang XO, Panopoulos AD, Nurieva R, Chang SH, Wang D, Watowich SS, 
et al. STAT3 regulates cytokine-mediated generation of inflammatory helper 
T cells. J Biol Chem (2007) 282:9358–63. doi:10.1074/jbc.C600321200 
10. Pan F, Ye Z, Cheng L, Liu JO. Myocyte enhancer factor 2 mediates calcium- 
dependent transcription of the interleukin-2 gene in T lymphocytes: a calcium 
signaling module that is distinct from but collaborates with the nuclear factor 
of activated T cells (NFAT). J Biol Chem (2004) 279:14477–80. doi:10.1074/
jbc.C300487200 
11. Zhang F, Meng G, Strober W. Interactions among the transcription factors 
Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 
17-producing T cells. Nat Immunol (2008) 9:1297–306. doi:10.1038/ni.1663 
12. Schraml BU, Hildner K, Ise W, Lee WL, Smith WA, Solomon B, et al. The AP-1 
transcription factor BATF controls T(H)17 differentiation. Nature (2009) 
460:405–9. doi:10.1038/nature08114 
13. Chen Z, Laurence A, Kanno Y, Pacher-Zavisin M, Zhu BM, Tato C, et al. Selective 
regulatory function of Socs3 in the formation of IL-17-secreting T cells. Proc 
Natl Acad Sci U S A (2006) 103:8137–42. doi:10.1073/pnas.0600666103 
14. Durant L, Watford WT, Ramos HL, Laurence A, Vahedi G, Wei L, et al. Diverse 
targets of the transcription factor STAT3 contribute to T cell pathogenicity and 
homeostasis. Immunity (2010) 32:605–15. doi:10.1016/j.immuni.2010.05.003 
15. Bi Y, Liu G, Yang R. Th17 cell induction and immune regulatory effects. J Cell 
Physiol (2007) 211:273–8. doi:10.1002/jcp.20973 
16. Hess J, Angel P, Schorpp-Kistner M. AP-1 subunits: quarrel and har-
mony among siblings. J Cell Sci (2004) 117:5965–73. doi:10.1242/jcs. 
01589 
17. Thomsen MK, Bakiri L, Hasenfuss SC, Hamacher R, Martinez L, Wagner EF. 
JUNB/AP-1 controls IFN-gamma during inflammatory liver disease. J Clin 
Invest (2013) 123:5258–68. doi:10.1172/JCI70405 
18. Pirusian ES, Nikol’skaia TA, Abdeev RM, Bruskin SA. Transcription factor 
AP-1 components as a psoriasis candidate genes. Mol Biol (Mosk) (2007) 
41:1069–80.
19. Sabatakos G, Rowe GC, Kveiborg M, Wu M, Neff L, Chiusaroli R, et  al. 
Doubly truncated FosB isoform (Delta2DeltaFosB) induces osteosclerosis in 
transgenic mice and modulates expression and phosphorylation of Smads in 
osteoblasts independent of intrinsic AP-1 activity. J Bone Miner Res (2008) 
23:584–95. doi:10.1359/jbmr.080110 
11
Moon et al. FRA-1/JUNB Induce Th17 and Arthritis
Frontiers in Immunology | www.frontiersin.org December 2017 | Volume 8 | Article 1793
20. Eferl R, Hasselblatt P, Rath M, Popper H, Zenz R, Komnenovic V, et  al. 
Development of pulmonary fibrosis through a pathway involving the tran-
scription factor FRA-2/AP-1. Proc Natl Acad Sci U S A (2008) 105:10525–30. 
doi:10.1073/pnas.0801414105 
21. Min L, Ji Y, Bakiri L, Qiu Z, Cen J, Chen X, et al. Liver cancer initiation is 
controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat Cell 
Biol (2012) 14:1203–11. doi:10.1038/ncb2590 
22. Coquet JM, Middendorp S, van der Horst G, Kind J, Veraar EA, Xiao Y, et al. 
The CD27 and CD70 costimulatory pathway inhibits effector function of T 
helper 17 cells and attenuates associated autoimmunity. Immunity (2013) 
38:53–65. doi:10.1016/j.immuni.2012.09.009 
23. Lee SM, Gao B, Fang D. FoxP3 maintains Treg unresponsiveness by selec-
tively inhibiting the promoter DNA-binding activity of AP-1. Blood (2008) 
111:3599–606. doi:10.1182/blood-2007-09-115014 
24. Huo L, Rothstein TL. Isolation and characterization of murine FRA-1: 
induction mediated by CD40 and surface Ig is protein kinase C dependent. 
J Immunol (1996) 157:3812–8. 
25. Szremska AP, Kenner L, Weisz E, Ott RG, Passegue E, Artwohl M, et al. JUNB 
inhibits proliferation and transformation in B-lymphoid cells. Blood (2003) 
102:4159–65. doi:10.1182/blood-2003-03-0915 
26. Song H, Wang R, Wang S, Lin J. A low-molecular-weight compound 
discovered through virtual database screening inhibits STAT3 function in 
breast cancer cells. Proc Natl Acad Sci U S A (2005) 102:4700–5. doi:10.1073/
pnas.0409894102 
27. Jochum W, Passegue E, Wagner EF. AP-1 in mouse development and tumori-
genesis. Oncogene (2001) 20:2401–12. doi:10.1038/sj.onc.1204389 
28. Lundy SK, Sarkar S, Tesmer LA, Fox DA. Cells of the synovium in rheuma-
toid arthritis. T  lymphocytes. Arthritis Res Ther (2007) 9:202. doi:10.1186/ 
ar2107 
29. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17  cells in human disease. 
 Immunol Rev (2008) 223:87–113. doi:10.1111/j.1600-065X.2008.00628.x 
30. Hietala MA, Jonsson IM, Tarkowski A, Kleinau S, Pekna M. Complement 
deficiency ameliorates collagen-induced arthritis in mice. J Immunol (2002) 
169:454–9. doi:10.4049/jimmunol.169.1.454 
31. Jariel-Encontre I, Salvat C, Steff AM, Pariat M, Acquaviva C, Furstoss O, et al. 
Complex mechanisms for c-FOS and c-JUN degradation. Mol Biol Rep (1997) 
24:51–6. doi:10.1023/A:1006804723722 
32. Stancovski I, Gonen H, Orian A, Schwartz AL, Ciechanover A. Degradation 
of the proto-oncogene product c-FOS by the ubiquitin proteolytic 
system in  vivo and in  vitro: identification and characterization of the 
conjugating enzymes. Mol Cell Biol (1995) 15:7106–16. doi:10.1128/MCB. 
15.12.7106 
33. Bakiri L, Matsuo K, Wisniewska M, Wagner EF, Yaniv M. Promoter speci-
ficity and biological activity of tethered AP-1 dimers. Mol Cell Biol (2002) 
22:4952–64. doi:10.1128/MCB.22.13.4952-4964.2002 
34. Sharma SC, Richards JS. Regulation of AP1 (JUN/FOS) factor expression 
and activation in ovarian granulosa cells. Relation of JUND and FRA2 to 
terminal differentiation. J Biol Chem (2000) 275:33718–28. doi:10.1074/jbc.
M003555200 
35. Boise LH, Petryniak B, Mao X, June CH, Wang CY, Lindsten T, et  al. The 
NFAT-1 DNA binding complex in activated T cells contains FRA-1 and JUNB. 
Mol Cell Biol (1993) 13:1911–9. doi:10.1128/MCB.13.3.1911 
36. Ciofani M, Madar A, Galan C, Sellars M, Mace K, Pauli F, et al. A validated 
regulatory network for Th17  cell specification. Cell (2012) 151:289–303. 
doi:10.1016/j.cell.2012.09.016 
37. Leu JI, Crissey MA, Leu JP, Ciliberto G, Taub R. Interleukin-6-induced STAT3 
and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation 
of hepatic genes, an adaptive response to liver injury. Mol Cell Biol (2001) 
21:414–24. doi:10.1128/MCB.21.2.414-424.2001 
38. Song Y, Qian L, Song S, Chen L, Zhang Y, Yuan G, et al. FRA-1 and STAT3 
synergistically regulate activation of human MMP-9 gene. Mol Immunol 
(2008) 45:137–43. doi:10.1016/j.molimm.2007.04.031 
39. Li P, Spolski R, Liao W, Wang L, Murphy TL, Murphy KM, et al. BATF-JUN is 
critical for IRF4-mediated transcription in T cells. Nature (2012) 490:543–6. 
doi:10.1038/nature11530 
Conflict of Interest Statement: The authors declare that the research was 
conducted in the absence of any commercial or financial relationships that could 
be construed as a potential conflict of interest.
Copyright © 2017 Moon, Lee, Kwok, Lee, Kim, Kim, Her, Son, Kim, Ryu, Seo, Kwon, 
Hwang, Youn, Seong, Jue, Park, Kim, Ahn and Cho. This is an open-access article 
distributed under the terms of the Creative Commons Attribution License (CC BY). 
The use, distribution or reproduction in other forums is permitted, provided the 
original author(s) or licensor are credited and that the original publication in this 
journal is cited, in accordance with accepted academic practice. No use, distribution 
or reproduction is permitted which does not comply with these terms.
